SolarEdge Technologies (NASDAQ:SEDG) -4.2% in Monday's trading after TD Cowen downgraded shares to Hold from Buy with a $16 ...

TD Cowen downgraded SolarEdge Technologies (NASDAQ:SEDG) from Buy to Hold in a research note, citing ongoing challenges in ...

Fintel reports that on October 21, 2024, TD Cowen downgraded their outlook for SolarEdge Technologies (NasdaqGS:SEDG) from ...

TD Cowen downgraded SolarEdge (SEDG) to Hold from Buy with a price target of $16, down from $35. The firm cites deteriorating demand in Europe for the downgrade. This will delay a volume, margin ...

SolarEdge Technologies continues to grapple with slowing demand in Europe and it’s time to step back on shares of the ...

SolarEdge Technologies (SEDG – Research Report), the Technology sector company, was revisited by a Wall Street analyst today. Analyst Jeff Osborne from TD Cowen downgraded the rating on the stock to a ...

TD Cowen upgraded Universal Health Services stock from Hold to Buy, catapulting its price target from $220 to $283 per share.Market Domination anchors Julie Hyman and Josh Lipton discuss TD Cowen ...

TD Cowen on potential opportunities in Canadian equities. The potential impact of Canadian mortgage resets in 2025. Why demographic uncertainty could be a major challenge for the Canadian economy.

TD Cowen has maintained its Hold rating on Snap Inc (NYSE: NYSE:SNAP) with a steady price target of $11.00. The firm's analysis projects that Snap will report a slowdown in revenue growth for the ...

TD Cowen has maintained a positive outlook on SentinelOne Inc (NYSE: S), reiterating a Buy rating and a price target of $35.00. The firm's analysis highlighted several key factors that support ...

TD Cowen upgraded Universal Health Services stock (UHS) from Hold to Buy, catapulting its price target from $220 to $283 per share. Market Domination anchors Julie Hyman and Josh Lipton discuss TD ...

On Wednesday, TD Cowen maintained its Hold rating on shares of 10X Genomics (NASDAQ:TXG) with a consistent price target of $18.00. The firm's stance comes in response to the company's release of ...